The Pediatric Proton/Photon Consortium Registry (PPCR) is a research study that aims to learn from every child and young adult treated with radiation

Joined July 2020
The PPCR joins the National Brain Tumor Society (@NBTStweets) and countless others in recognition of Brain Tumor Awareness Month. The month of May is dedicated to supporting, empowering, and amplifying the voice of the brain tumor community. #GrayMay
3
You can learn more about @PPCRdata's exciting new partnership with @oncoramed here: bit.ly/2Krzpx6
2
Happy Halloween from the Pediatric Radiation Registry team! Have a fun and safe weekend 馃巸
Pediatric cancers comprise a simultaneously rare but highly varied cadre of diseases. Among participants with non-central nervous system tumors in the PPCR, rhabdomyosarcoma (n=366), Ewings sarcoma (n=193), and neuroblastoma (n=177) are the most common.
1
3
The majority of our PPCR participants have a central nervous system (CNS) tumor diagnosis. Reference the chart for a histology breakdown.
2
Our project manager, Sara Gallotto, presenting at the @CI4CC Fall 2020 Symposium on the topic of using natural language processing and automation to better collect @PPCRdata
2
Meet the team! Torunn Yock, MD, is the Director of Pediatric Radiation Oncology at Massachusetts General Hospital and a Professor at Harvard Medical School. She is also the Primary Investigator for the Pediatric Proton/Photon Consortium Registry (PPCR)!
1
2
Dr. Torunn Yock discusses the benefits of treating cancer patients with proton radiotherapy. Read more here: rb.gy/pz1qiq
1
2